Brief: Index Pharmaceuticals Q2 Operating Loss At SEK 15.6 Mln

Flerie AB

26/08/2020 07:12

Aug 26 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * Q2 OPERATING LOSS SEK 15.6 MILLION VERSUS LOSS SEK 17.7
MILLION
YEAR AGO
    * WE CONTINUE WORK TO FINALIZE PHASE III DESIGN AND
ASSOCIATED
FINANCING

Source text for Eikon:  ID:nWkr3vy1mq 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))